Zimmer Biomet shared early results of a study evaluating its app for sufferers who underwent knee replacements to plain affected person training and bodily remedy. In line with preliminary knowledge, which has not but been peer reviewed, the corporate’s mymobility app noticed related outcomes to conventional care fashions, with fewer bodily remedy visits.
Zimmer Biomet, which producers surgical units for joint and knee replacements, developed the app. It connects sufferers with their surgical care staff earlier than and after their process, supplies guided workout routines, and pulls in exercise knowledge from sufferers’ Apple Watch. That knowledge, together with their steps, coronary heart charge and what number of flights of stairs they climbed within the final week, can be shared with clinicians.
The randomized, open-label trial included greater than 16 surgical websites. It had 224 sufferers within the management group, who obtained the usual of care earlier than and after a knee substitute, usually together with bodily remedy. One other 192 sufferers had been supplied an Apple Watch and the mymobility app. They may additionally obtain bodily remedy if deemed obligatory by a surgeon.
After 90 days, sufferers had been assessed by their knee vary of movement, whether or not they may stability on one leg for 30 seconds, how lengthy it takes them to face up and sit down, and whether or not they wanted manipulation underneath anesthesia following the surgical procedure. Sufferers additionally had been scored utilizing KOOS Jr, a survey on sufferers’ knee stiffness, ache and each day residing perform.
Outcomes shared on the American Affiliation of Hip and Knee Surgeons on Thursday confirmed that the distinction in knee flexion, knee extension, and KOOS Jr scores weren’t considerably totally different between the 2 teams. Sufferers who had been assigned the mymobility app had fewer bodily remedy visits.
“We’re very excited to debut early outcomes from one of many largest scientific research in orthopedics designed to guage the influence of the mymobility distant care administration platform on affected person outcomes and general prices of care,” Yvonne Bokelman, Zimmer Biomet’s vp of scientific affairs and market entry, said in a news release.
The research, which was funded by Zimmer Biomet, is still ongoing.
Photograph credit score: Apple